Cravatt Benjamin
SEC insider (Form 3/4/5 filer). CIK 0001819573. Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 1, 2026. Located in CAMBRIDGE, MA.
Companies Cravatt Benjamin has filed insider reports for
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
Cravatt Benjamin
CIK: 0001819573
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Director